期刊
HEART FAILURE CLINICS
卷 10, 期 3, 页码 407-+出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.hfc.2014.04.008
关键词
Heart failure with preserved ejection fraction; Phenotype; Phenomics; Etiology; Pathophysiology; Classification; Clinical trials
资金
- National Institutes of Health [R01 HL107577]
- American Heart Association [0835488N]
- NIH [K08 HL098361]
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome, with several underlying etiologic and pathophysiologic factors. The heterogeneity of the HFpEF syndrome may explain why (1) diagnosing and treating HFpEF is so challenging and (2) clinical trials in HFpEF have failed thus far. Here we describe 4 ways of categorizing HFpEF based on pathophysiology, clinical/etiologic subtype, type of clinical presentation, and quantitative phenomics (phenomapping analysis). Regardless of the classification method used, improved phenotypic characterization of HFpEF, and matching targeted therapies with specific HFpEF subtypes, will be a critical step towards improving outcomes in this increasingly prevalent syndrome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据